Chemcrux Enterprises Limited
BSE: CHEMCRUX · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Chemcrux Enterprises Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Chemcrux Enterprises Limited is a specialty chemicals manufacturer based in Gujarat, focusing on high-value intermediates produced through processes like chlorination, nitration, and sulfonation. The company serves the pharmaceutical, bulk drug, and agrochemical industries with custom synthesis capabilities.
Business Model
The company generates revenue by manufacturing and supplying specialized chemical intermediates for global pharmaceutical and agrochemical manufacturers. It leverages its R&D capabilities and ISO-certified manufacturing facility in Ankleshwar to provide custom synthesis solutions.
Growth Outlook
Growth is driven by the company's expansion into international markets including Europe, Egypt, and the United States. Continued focus on custom synthesis and high-value chemical intermediates for active pharmaceutical ingredients supports its niche market position.
Key Risks
- Regulatory and Environmental Compliance. The chemical manufacturing sector is subject to stringent environmental regulations that may necessitate significant capital expenditure for compliance.
- Raw Material Price Volatility. Fluctuations in the cost of chemical feedstocks can adversely impact profit margins if the company is unable to pass costs to customers.
- Geopolitical and Export Risks. As an exporter to multiple international regions, the company is exposed to currency fluctuations and changes in global trade policies.
- Operational Concentration. Reliance on a single manufacturing facility in Ankleshwar creates vulnerability to localized disruptions or operational failures.
Start your research today
Unlock AI insights, financials, peers and live data on Chemcrux Enterprises Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹81 Cr
TTM · consolidated
NET PROFIT
₹4 Cr
TTM · consolidated
EPS
₹2.51
TTM · consolidated
RETURN ON EQUITY
5.0%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
8.0%
TTM · consolidated
P/E
35.9x
Q4 FY26 · consolidated
EV/EBITDA
11.5x
Q4 FY26 · consolidated
EBITDA MARGIN
16.3%
TTM · consolidated
NET PROFIT MARGIN
7.6%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.4%
Q4 FY26 · consolidated
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Chemcrux Enterprises LimitedCHEMCRUX | ₹125 Cr | 33.65 | 11.88 | 15.2% | 16.3% | 5.0% | 8.0% | -25.0% |
Kronox Lab Sciences LimitedKRONOX | ₹666 Cr | 23.05 | 16.30 | 6.1% | 38.7% | 27.7% | 35.9% | +11.2% |
Black Rose IndusBLACKROSE | ₹584 Cr | 26.01 | 16.40 | — | 11.0% | 13.9% | 18.9% | +19.1% |
Vipul OrganicsVIPULORG | ₹506 Cr | 63.11 | 30.62 | 7.7% | 10.4% | 8.9% | 13.4% | +29.6% |
Plastiblends India LimitedPLASTIBLEN | ₹493 Cr | 11.54 | 6.83 | 5.5% | 9.2% | 9.7% | 12.8% | +0.5% |
Aarti SurfactantAARTISURF | ₹458 Cr | 24.91 | 9.80 | 25.2% | 6.1% | 7.7% | 12.4% | +19.0% |
As of Q4 FY26
Financials
Chemcrux Enterprises Limited
BSE: CHEMCRUX · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Chemcrux Enterprises Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Chemcrux Enterprises Limited is a specialty chemicals manufacturer based in Gujarat, focusing on high-value intermediates produced through processes like chlorination, nitration, and sulfonation. The company serves the pharmaceutical, bulk drug, and agrochemical industries with custom synthesis capabilities.
Business Model
The company generates revenue by manufacturing and supplying specialized chemical intermediates for global pharmaceutical and agrochemical manufacturers. It leverages its R&D capabilities and ISO-certified manufacturing facility in Ankleshwar to provide custom synthesis solutions.
Growth Outlook
Growth is driven by the company's expansion into international markets including Europe, Egypt, and the United States. Continued focus on custom synthesis and high-value chemical intermediates for active pharmaceutical ingredients supports its niche market position.
Key Risks
- Regulatory and Environmental Compliance. The chemical manufacturing sector is subject to stringent environmental regulations that may necessitate significant capital expenditure for compliance.
- Raw Material Price Volatility. Fluctuations in the cost of chemical feedstocks can adversely impact profit margins if the company is unable to pass costs to customers.
- Geopolitical and Export Risks. As an exporter to multiple international regions, the company is exposed to currency fluctuations and changes in global trade policies.
- Operational Concentration. Reliance on a single manufacturing facility in Ankleshwar creates vulnerability to localized disruptions or operational failures.
Start your research today
Unlock AI insights, financials, peers and live data on Chemcrux Enterprises Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹81 Cr
TTM · consolidated
NET PROFIT
₹4 Cr
TTM · consolidated
EPS
₹2.51
TTM · consolidated
RETURN ON EQUITY
5.0%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
8.0%
TTM · consolidated
P/E
35.9x
Q4 FY26 · consolidated
EV/EBITDA
11.5x
Q4 FY26 · consolidated
EBITDA MARGIN
16.3%
TTM · consolidated
NET PROFIT MARGIN
7.6%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.4%
Q4 FY26 · consolidated
Peers · Specialty Chemicals
As of Q4 FY26